NZ shares rise as vaccine trial boosts global sentiment
New Zealand shares rose for a third day as investors welcomed interim results of a covid-19 vaccine trial which showed a positive immune response to the virus.
BusinessDesk
Stories written by multiple reporters.
Followers will be emailed articles by BusinessDesk